Research Progress on Peptide Drugs for Type 2 Diabetes and the Possibility of Oral Administration
Diabetes is a global disease that can lead to a range of complications. Currently, the treatment of type 2 diabetes focuses on oral hypoglycemic drugs and insulin analogues. Studies have shown that drugs such as oral metformin are useful in the treatment of diabetes but can limit the liver’s ability...
Saved in:
| Main Authors: | Xinxin Yang, Ruiting Lin, Changzhuo Feng, Qiyuan Kang, Peng Yu, Yongzhi Deng, Ye Jin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/16/11/1353 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obstacles, research progress, and prospects of oral delivery of bioactive peptides: a comprehensive review
by: Xinyu Wang, et al.
Published: (2024-11-01) -
Research progress of novel anti-tumor drug formulations
by: Yan Liu, et al.
Published: (2024-12-01) -
Breath and Beyond: Advances in Nanomedicine for Oral and Intranasal Aerosol Drug Delivery
by: Simeng Du, et al.
Published: (2024-12-01) -
Nanotechnology in Drug Delivery: Anatomy and Molecular Insight into the Self-Assembly of Peptide-Based Hydrogels
by: Adelaide R. Mashweu, et al.
Published: (2024-11-01) -
A Systematic Review of Spironolactone Nano-Formulations for Topical Treatment of Skin Hyperandrogenic Disorders and Chronic Wounds
by: Saedah Dereiah, et al.
Published: (2024-12-01)